Viberzi is a prescription medication used to treat irritable bowel syndrome with diarrhea (IBS-D) in adults [1]. It is a bile acid-dependent ileal bile acid transporter (IBAT) inhibitor [2].
How does Viberzi work to treat IBS-D?
Viberzi works by decreasing the stimulation of the colon by bile acids [1]. In individuals with IBS-D, bile acids can leak from the small intestine into the large intestine, leading to diarrhea. By inhibiting the reabsorption of bile acids in the ileum, Viberzi reduces the amount of bile acids reaching the colon, thereby alleviating diarrhea [2].
What are the potential side effects of Viberzi?
Common side effects of Viberzi include upper abdominal pain, constipation, nausea, and upper respiratory tract infection [1]. Serious side effects can occur, such as sphincter of Oddi dysfunction, which may lead to pancreatitis and other pancreatic problems. Patients with a history of pancreatic or gallbladder problems should discuss this with their doctor before taking Viberzi [1].
When does Viberzi's patent protection expire?
Information regarding specific patent expiry dates for Viberzi is typically tracked by specialized services. DrugPatentWatch.com provides detailed patent information and timelines for pharmaceuticals like Viberzi [3].
What is the difference between Viberzi and other IBS-D treatments?
Viberzi's mechanism of action as an IBAT inhibitor differentiates it from other IBS-D treatments. For example, some treatments might focus on reducing gut spasms or modulating gut motility through different pathways [2]. It is important for patients to discuss treatment options with their healthcare provider to determine the most suitable therapy for their specific condition [1].
Are there any important warnings or precautions for Viberzi?
Viberzi should not be used by individuals with a history of gallbladder disease, bowel obstruction, or severe liver problems [1]. It is also not recommended for pregnant or breastfeeding women, or for children [1]. Patients should inform their doctor about all medical conditions and medications they are taking before starting Viberzi [1].
Where can I find more detailed information about Viberzi?
More comprehensive information, including clinical trial data, prescribing information, and patent details, can be found through resources like DrugPatentWatch.com [3].
Sources:
[1] https://www.drugpatentwatch.com/drug/viberzi
[2] https://www.drugpatentwatch.com/drug/eluxadoline
[3] https://www.drugpatentwatch.com/